| TNFSF14: LIGHTing the way for effective cancer immunotherapy JG Skeate, ME Otsmaa, R Prins, DJ Fernandez, DM Da Silva, WM Kast Frontiers in Immunology 11, 922, 2020 | 65 | 2020 |
| Development and characterization of a novel luciferase based cytotoxicity assay H Matta, R Gopalakrishnan, S Choi, R Prakash, V Natarajan, R Prins, ... Scientific reports 8 (1), 1-14, 2018 | 53 | 2018 |
| A novel luciferase-based assay for the detection of Chimeric Antigen Receptors R Gopalakrishnan, H Matta, S Choi, V Natarajan, R Prins, S Gong, ... Scientific reports 9 (1), 1-13, 2019 | 22 | 2019 |
| Theta-defensins inhibit high-risk human papillomavirus infection through charge-driven capsid clustering JG Skeate, WH Segerink, MD Garcia, DJ Fernandez, R Prins, KP Lühen, ... Frontiers in Immunology 11, 561843, 2020 | 10 | 2020 |
| 1084 NTX-0250, a multimodal mRNA-based immunotherapy, eradicates large established tumors in a stringent mouse model of HPV16-driven cancer O Haabeth, D DaSilva, C McKinlay, W Liu, E Lemmens, C Rae, A Sallets, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| NTX-0250, A MULTIMODAL MRNA-BASED IMMUNOTHERAPY, ERADICATES LARGE ESTABLISHED TUMORS IN A STRINGENT MOUSE MODEL OF HPV16DRIVEN CANCER O Haabeth, D DaSilva, C McKinlay, W Liu, E Lemmens, C Rae, A Sallets, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A1126-A1126, 2022 | | 2022 |
| 1084 NTX-0250, a multimodal mRNA-based immunotherapy, eradicates large established tumors in a stringent mouse model of HPV16-driven cancer O Haabeth, D DaSilva, C McKinlay, W Liu, E Lemmens, C Rae, A Sallets, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| A novel luciferase-based assay for the detection of Chimeric Antigen Receptors G Ramakrishnan, M Hittu, C Sunju, N Venkatesh, R Prins, G Songjie, ... Scientific Reports (Nature Publisher Group) 9 (1), 2019 | | 2019 |
| Treatment of HPV Driven Tumors with SH5-07, a Small Molecule Inhibitor Targeting STAT3 R Prins University of Southern California, 2019 | | 2019 |
| A Novel Method for Highly Sensitive Detection and Isolation of Chimeric Antigen Receptor and Cancer Associated Antigen-Expressing Cells R Gopalakrishnan, H Matta, S Choi, V Natarajan, R Prins, S Gong, ... Blood 130 (Supplement 1), 1915-1915, 2017 | | 2017 |
WM KastUniversity of Southern CaliforniaVerified email at med.usc.edu
